Literature DB >> 21386195

A chemometric study on human breath mass spectra for biomarker identification in cystic fibrosis.

L Bennett1, L Ciaffoni, W Denzer, G Hancock, A D Lunn, R Peverall, S Praun, G A D Ritchie.   

Abstract

Alveolar breath samples from a small case-control study population have been collected and measured via ion-molecule reaction mass spectrometry, and a constructive statistical approach to the identification of volatile biomarkers has been formulated by applying multivariate statistical methods on the mass spectra. The nature of the data is such that the number of variables largely exceeds the observations, representing a typical experimental scenario when breath analysis is conducted using mass spectrometry. Principal components analysis has been performed on the high dimensional dataset of molecular abundances, providing evidence of case separation and reducing the number of functional discriminators by almost 90%. Afterwards, a deductive approach based on a binary regression was conducted on the reduced dataset, providing an entirely reliable case discrimination model exclusively depending on the concentrations in the breath mixture of 3 out of a total of 97 metabolites.

Entities:  

Year:  2009        PMID: 21386195     DOI: 10.1088/1752-7155/3/4/046002

Source DB:  PubMed          Journal:  J Breath Res        ISSN: 1752-7155            Impact factor:   3.262


  7 in total

Review 1.  Electronic Nose Technology in Respiratory Diseases.

Authors:  Silvano Dragonieri; Giorgio Pennazza; Pierluigi Carratu; Onofrio Resta
Journal:  Lung       Date:  2017-02-25       Impact factor: 2.584

2.  Application of Cavity Enhanced Absorption Spectroscopy to the Detection of Nitric Oxide, Carbonyl Sulphide, and Ethane--Breath Biomarkers of Serious Diseases.

Authors:  Jacek Wojtas
Journal:  Sensors (Basel)       Date:  2015-06-17       Impact factor: 3.576

3.  Exhaled volatile organic compounds analysis in clinical pediatrics: a systematic review.

Authors:  Rosa A Sola Martínez; José M Pastor Hernández; Óscar Yanes Torrado; Manuel Cánovas Díaz; Teresa de Diego Puente; María Vinaixa Crevillent
Journal:  Pediatr Res       Date:  2020-09-12       Impact factor: 3.756

Review 4.  Integration of biosensors and drug delivery technologies for early detection and chronic management of illness.

Authors:  Mpho Ngoepe; Yahya E Choonara; Charu Tyagi; Lomas Kumar Tomar; Lisa C du Toit; Pradeep Kumar; Valence M K Ndesendo; Viness Pillay
Journal:  Sensors (Basel)       Date:  2013-06-14       Impact factor: 3.576

5.  Gram-negative and -positive bacteria differentiation in blood culture samples by headspace volatile compound analysis.

Authors:  Michael E Dolch; Silke Janitza; Anne-Laure Boulesteix; Carola Graßmann-Lichtenauer; Siegfried Praun; Wolfgang Denzer; Gustav Schelling; Sören Schubert
Journal:  J Biol Res (Thessalon)       Date:  2016-03-12       Impact factor: 1.889

6.  Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry.

Authors:  Lorenzo Monasta; Chiara Pierobon; Andrea Princivalle; Stefano Martelossi; Annalisa Marcuzzi; Francesco Pasini; Luigi Perbellini
Journal:  PLoS One       Date:  2017-08-31       Impact factor: 3.240

7.  Pancreatic ductal adenocarcinoma can be detected by analysis of volatile organic compounds (VOCs) in alveolar air.

Authors:  Andrea Princivalle; Lorenzo Monasta; Giovanni Butturini; Claudio Bassi; Luigi Perbellini
Journal:  BMC Cancer       Date:  2018-05-04       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.